Form 4: Xylem Inc. Executive Claudia S. Toussaint Reports Stock and Option Awards
SEC Form 4 Filing
Claudia S. Toussaint, SVP, CPSO of Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
Summary
- On March 5, 2025, Claudia S. Toussaint, SVP, CPSO of Xylem Inc., was granted 2,024 shares of common stock at a price of $129.67.
- These shares are in the form of restricted stock units that will vest in equal installments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Additionally, Toussaint was granted 7,104 non-qualified stock options with an exercise price of $129.67, also vesting in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Following these transactions, Toussaint directly owns 10,136 shares of common stock and indirectly owns 35,474 shares through the Claudia S. Toussaint Revocable Trust.
- She also directly owns 7,104 non-qualified stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, indicating confidence in the company's future performance. The vesting schedule promotes long-term alignment.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the granted securities.
Industry Context
Stock and option awards are a common practice in executive compensation packages within publicly traded companies to incentivize performance and align management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Xylem.
- Companies such as Danaher, Roper Technologies, and Honeywell also utilize similar equity-based compensation to incentivize their executives.
- The vesting schedules, typically spanning three to five years, are also consistent with industry norms to promote long-term commitment.
Stakeholder Impact
- The stock and option awards can positively impact shareholders by aligning executive interests with company performance.
- Employees may view the awards as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| February 24, 2016 | Date of the Amended and Restated Xylem 2011 Omnibus Incentive Plan. |
| March 5, 2025 | Date of the reported transactions: acquisition of restricted stock units and non-qualified stock options. |
| March 5, 2026 | First vesting date for both the restricted stock units and non-qualified stock options. |
| March 5, 2027 | Second vesting date for both the restricted stock units and non-qualified stock options. |
| March 5, 2028 | Final vesting date for both the restricted stock units and non-qualified stock options. |
| March 5, 2035 | Expiration date for the non-qualified stock options. |
| March 6, 2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.